333 related articles for article (PubMed ID: 32861641)
1. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
[TBL] [Abstract][Full Text] [Related]
2. Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice.
Ludka FK; Constantino LC; Dal-Cim T; Binder LB; Zomkowski A; Rodrigues AL; Tasca CI
J Psychiatr Res; 2016 Nov; 82():50-7. PubMed ID: 27468164
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway.
Moretti M; Budni J; Freitas AE; Rosa PB; Rodrigues AL
J Psychiatr Res; 2014 Jan; 48(1):16-24. PubMed ID: 24209999
[TBL] [Abstract][Full Text] [Related]
4. Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.
Pazini FL; Cunha MP; Rosa JM; Colla AR; Lieberknecht V; Oliveira Á; Rodrigues AL
Mol Neurobiol; 2016 Dec; 53(10):6818-6834. PubMed ID: 26660117
[TBL] [Abstract][Full Text] [Related]
5. Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine.
Cunha MP; Budni J; Ludka FK; Pazini FL; Rosa JM; Oliveira Á; Lopes MW; Tasca CI; Leal RB; Rodrigues ALS
Mol Neurobiol; 2016 Jul; 53(5):2954-2968. PubMed ID: 25943184
[TBL] [Abstract][Full Text] [Related]
6. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.
Lu Y; Wang C; Xue Z; Li C; Zhang J; Zhao X; Liu A; Wang Q; Zhou W
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25542689
[TBL] [Abstract][Full Text] [Related]
7. Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways.
Bettio LE; Cunha MP; Budni J; Pazini FL; Oliveira Á; Colla AR; Rodrigues AL
Behav Brain Res; 2012 Oct; 234(2):137-48. PubMed ID: 22743004
[TBL] [Abstract][Full Text] [Related]
8. Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.
Neis VB; Moretti M; Bettio LE; Ribeiro CM; Rosa PB; Gonçalves FM; Lopes MW; Leal RB; Rodrigues AL
Eur Neuropsychopharmacol; 2016 Jun; 26(6):959-71. PubMed ID: 27061850
[TBL] [Abstract][Full Text] [Related]
9. The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways.
Rosa PB; Bettio LEB; Neis VB; Moretti M; Werle I; Leal RB; Rodrigues ALS
Purinergic Signal; 2019 Dec; 15(4):491-504. PubMed ID: 31768875
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic efficacy of ketamine, but not the low-trapping NMDA receptor antagonist AZD6765, against stress-induced maladaptive behavior and 4E-BP1-related synaptic protein synthesis impairment.
Camargo A; Torrá ACNC; Dalmagro AP; Valverde AP; Kouba BR; Fraga DB; Alves EC; Rodrigues ALS
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Apr; 115():110509. PubMed ID: 35033626
[TBL] [Abstract][Full Text] [Related]
11. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
12. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.
Suzuki A; Murakami K; Tajima Y; Hara H; Kunugi A; Kimura H
Pharmacol Biochem Behav; 2019 Aug; 183():80-86. PubMed ID: 31202810
[TBL] [Abstract][Full Text] [Related]
13. Isorhynchophylline exerts antidepressant-like effects in mice
Xian YF; Ip SP; Li HQ; Qu C; Su ZR; Chen JN; Lin ZX
FASEB J; 2019 Sep; 33(9):10393-10408. PubMed ID: 31233346
[TBL] [Abstract][Full Text] [Related]
14. mTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test.
Pazini FL; Rosa JM; Camargo A; Fraga DB; Moretti M; Siteneski A; Rodrigues ALS
Chem Biol Interact; 2020 Dec; 332():109281. PubMed ID: 33022268
[TBL] [Abstract][Full Text] [Related]
15. Matrine Exerts Antidepressant-Like Effects on Mice: Role of the Hippocampal PI3K/Akt/mTOR Signaling.
Wu Z; You Z; Chen P; Chen C; Chen F; Shen J; Xu H
Int J Neuropsychopharmacol; 2018 Aug; 21(8):764-776. PubMed ID: 29668939
[TBL] [Abstract][Full Text] [Related]
16. Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test.
Gonçalves FM; Neis VB; Rieger DK; Peres TV; Lopes MW; Heinrich IA; Costa AP; Rodrigues ALS; Kaster MP; Leal RB
J Neural Transm (Vienna); 2017 Oct; 124(10):1227-1237. PubMed ID: 28695335
[TBL] [Abstract][Full Text] [Related]
17. Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.
Szewczyk B; Pochwat B; Rafało A; Palucha-Poniewiera A; Domin H; Nowak G
Neuropharmacology; 2015 Dec; 99():517-26. PubMed ID: 26297535
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation.
Manosso LM; Moretti M; Ribeiro CM; Gonçalves FM; Leal RB; Rodrigues ALS
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():59-67. PubMed ID: 25600102
[TBL] [Abstract][Full Text] [Related]
19. Akt mediates GSK-3β phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions.
Zhou W; Dong L; Wang N; Shi JY; Yang JJ; Zuo ZY; Zhou ZQ
Neuroimmunomodulation; 2014; 21(4):183-8. PubMed ID: 24504086
[TBL] [Abstract][Full Text] [Related]
20. Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.
Ni RJ; Gao TH; Wang YY; Tian Y; Wei JX; Zhao LS; Ni PY; Ma XH; Li T
Zool Res; 2022 Nov; 43(6):989-1004. PubMed ID: 36257830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]